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Compositional marker in vivo 
reveals intramyocellular lipid 
turnover during fasting-induced 
lipolysis
Ajay Thankamony1, Graham J. Kemp2, Albert Koulman  3,4, Vlada Bokii5, David B. Savage4, 
Chris Boesch  6, Leanne Hodson7, David B. Dunger  1,4 & Alison Sleigh  4,5,8
Intramyocellular lipid (IMCL) is of particular metabolic interest, but despite many proton magnetic 
resonance spectroscopy (1H MRS) studies reporting IMCL content measured by the methylene 
(CH2) resonance signal, little is known about its composition. Here we validated IMCL CH3:CH2 ratio 
as a compositional marker using 1H MRS at short echo time, and investigated IMCL content and 
composition during a 28-hour fast in 24 healthy males. Increases in IMCL CH2 relative to the creatine and 
phosphocreatine resonance (Cr) at 3.0 ppm (an internal standard) correlated with circulating free fatty 
acid (FA) concentrations, supporting the concept of increased FA influx into IMCL. Significant decreases 
in IMCL CH3:CH2 ratio indicated a less unsaturated IMCL pool after fasting, and this compositional 
change related inversely to IMCL baseline composition, suggesting a selective efflux of unsaturated 
shorter-chain FA from the IMCL pool. This novel in vivo evidence reveals IMCL turnover during extended 
fasting, consistent with the concept of a flexible, responsive myocellular lipid store. There were also 
differences between soleus and tibialis anterior in basal IMCL composition and in response to fasting. 
We discuss the potential of this marker for providing insights into normal physiology and mechanisms 
of disease.
Intramyocellular lipids (IMCL) assemble as tiny droplets close to mitochondria and are dynamic functional orga-
nelles involved in lipid metabolism and cell signalling1,2. Associated with enzymes of fatty acid (FA) esterifica-
tion, hydrolysis and mitochondrial transport, they represent a metabolically active pool optimised for rapid FA 
turnover and oxidation. IMCL accumulation is associated with insulin resistance (IR)3–5, but the occurrence of 
increased IMCL also in states of high insulin sensitivity (the ‘athlete’s paradox’)6 has focused attention on related 
lipid intermediates (e.g. ceramide, diacylglycerol or long-chain fatty acyl CoA), rather than intramyocellular 
triglyceride (TG) per se, in impaired insulin signalling2.
Fasting-induced adipose tissue lipolysis releases free fatty acids (FFA) into circulation and IMCL are reported 
to increase7,8, in a fibre-specific manner8–11. This suggests that the relationship between FA availability and oxi-
dation, rather than circulating insulin, mainly determines IMCL content7. In fasting, both highly unsaturated FA 
and shorter-chained FA are preferentially mobilised from adipose tissue12,13, and a similar pattern is evident from 
changes in biopsy-measured rat muscle TG during an extended fast14. The mechanism for this preferential mobi-
lisation was thought to relate to the physico-chemical characteristics of individual fatty acids12,13, such as water 
solubility, but selective enzymological properties were not ruled out15.
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The unique ability of proton magnetic resonance spectroscopy (1H MRS) to non-invasively distinguish IMCL 
from extramyocellular lipid (EMCL)16,17 has led to its widespread use, reporting IMCL concentrations from the 
signal intensity of the methylene (CH2) resonance in FA chains in TG (the predominant species detected by 1H 
MRS18). However, CH2 signal is also influenced by lipid composition, a notional normal value being assumed to 
quantify IMCL. In contrast, the methyl (CH3) resonance is independent of lipid composition18, but measurement 
is hampered by its lower signal intensity and the overlapping EMCL CH3 resonance. To address this Ren et al.19 
exploited the spectral simplification of long echo time acquisition and the enhanced signal-to-noise and spectral 
resolution at 7 T. They proposed the CH3:CH2 ratio as a marker of IMCL TG composition19. However, at long echo 
times the reduction in signal and the need for accurate T2 correction19,20 pose challenges, and its practical utility 
has not been established.
Most muscle IMCL measurements are made at 3 T with a short echo time. We set out to test the feasibility 
of measuring the CH3 resonance under these conditions, using optimal quality spectra and fitting algorithms. 
To evaluate the CH3:CH2 ratio as a compositional marker, we measured it in vitro in phantoms simulating 
IMCL and EMCL. To study IMCL composition and dynamics during extended fasting we performed 1H MRS 
at short echo time in healthy males at both 8 h (a standard baseline time point for metabolic studies regard-
ing food intake) and 28 h of fast. We measured in vivo changes in CH2 (influenced both by TG amount and 
composition), CH3 (reporting only TG amount, and thus reflecting net FA influx-efflux) and CH3:CH2 (the 
compositional marker) in two leg muscles, the more oxidative soleus (SOL) and the more glycolytic tibialis 
anterior (TA), and related these to circulating FFA concentrations and changes in MRI-measured adipose 
tissue volumes.
Results and Discussion
Phantom validation. The IMCL CH3:CH2 ratio is sensitive to unsaturation, and to a lesser degree the chain 
length in intramyocellular TG (Fig. 1A). In agar phantoms simulating the combined IMCL and EMCL pools, the 
CH3:CH2 ratio correctly distinguished 4 different lipid compositions by their relative order (Fig. 1B, right). Bias 
due to factors including J-modulation, fitting prior knowledge, and T2 effects likely account for the systematic 
difference between observed and theoretical values, so ratio values were used comparatively. Figure 1B and C 
show representative spectra (and the corresponding fits) acquired from a phantom and from SOL in vivo, respec-
tively. The CH3 signal from omega-3 FA resonates at different frequencies to the CH3 resonance shown in Fig. 1, 
but as shown by biopsy, muscle TG contains very little (~1%) omega-3 lipids21 and so the fitting models we used 
disregard this.
In vivo fasting effects. The 24 healthy male participants were of mean ± SEM age 34.9 ± 1.8 years and 
BMI 23.4 ± 0.5 kg.m−2. Spectra with no clear distinction between EMCL and IMCL CH2 resonances were elim-
inated, yielding 22 and 19 complete pre- and post-fasting sets for TA and SOL respectively. IMCL CH2 relative 
to the internal standard creatine plus phosphocreatine (Cr) increased on extended fasting (Table 1), consistent 
with observations in longer fasts in human vastus lateralis7, TA and SOL8. FFA concentrations correlated with 
the fasting increment (Δ) in IMCL in both TA (ΔCH2: r = 0.57, p = 0.006; ΔCH3: r = 0.39, p = 0.07) and SOL 
(ΔCH2: r = 0.52, p = 0.02; ΔCH3: r = 0.47, p = 0.04), supporting the concept that FA influx into the cell controls 
IMCL pool size in these circumstances, either by directly altering the influx into the IMCL pool or indirectly by 
suppressing IMCL lipolysis. Subcutaneous adipose tissue (SCAT) decreased whilst other fat depots remained 
unchanged (Table 1), suggesting that SCAT is the main source of increased FFA in these non-obese males. This 
is consistent with studies of regional FFA release in vivo in humans using isotope techniques22 where upper body 
subcutaneous fat was by far the greatest contributor to systemic FFA release under basal conditions and during 
prolonged fasting. Direct validation studies would be needed to support this application of MRI in determining 
the dynamics of fat depots conveniently in vivo.
IMCL CH3/Cr (which unlike CH2/Cr, the increment in which purely reflects net FA flux) increased by ~12% 
in TA (p = 0.03) implying net FA influx during the fast, but not significantly in SOL. IMCL CH2/Cr increased 
by 26% in SOL (p = 0.007) and 31% in TA (p < 0.001) (Table 1). The IMCL CH2/Cr increase was therefore more 
than the increase in CH3/Cr and thus represents significant decreases in the compositional marker CH3:CH2 
(Table 1, Fig. 2A), indicating a change towards decreased unsaturation and possibly increased chain length of 
IMCL during fasting. These IMCL compositional changes on fasting correlated inversely with baseline IMCL 
composition in both muscles (Fig. 2A), suggesting a selective efflux of unsaturated and/or shorter chain FAs 
from the IMCL pool during fasting. This matches the mobilisation profile in a rat biopsy study of muscle TG14, 
in which the reduction in CH3:CH2 ratio was mainly due to the efflux of unsaturated and/or shorter chain FA. 
Supporting this notion, net efflux of FFA from the IMCL pool during the fast were associated with decreases in 
the compositional marker in both muscles (Fig. 2B). IMCL compositional changes were not associated with cir-
culating FFA or IMCL ΔCH2/Cr in either muscle (all p > 0.23). Together our observations indicate that during 
the fast an efflux of FA with a high CH3:CH2 ratio from the IMCL pool is the main determinant of compositional 
changes in IMCL.
Differences between muscles. There was a striking difference in baseline IMCL CH3:CH2 between mus-
cles (Table 1, Fig. 2C), TA having a more unsaturated shorter-chain TG pool than SOL. Modelling based on 
phantom results suggests that SOL lipid CH3:CH2 is similar to or more saturated than olive oil, and TA similar 
to sunflower oil. A possible contribution to these differences may result from inconsistencies in spectral fitting 
between muscles due to slightly different EMCL resonant frequencies that depend on fibre orientations; however, 
this is unlikely to fully explain these differences. Biopsy TG samples processed by normal methods are prone to 
EMCL contamination, and there is little published data on the composition in these muscles; we cautiously sug-
gest that such a difference in IMCL composition might explain reported differences in determinants of IMCL23.
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Figure 1. 1H-MRS intramyocellular lipid (IMCL): the CH3:CH2 ratio as a compositional marker in theory, 
in phantoms, and in vivo. (A) Theory. The figure shows the principle of the CH3:CH2 ratio as a compositional 
marker in IMCL (which detected by 1H MRS is overwhelmingly triglyceride (TG)34), influenced primarily 
by the degree of fatty acid (FA) unsaturation, and secondarily by FA chain length. The upper panel shows the 
palmitic acid component of a TG molecule with the theoretical ratio of 3/24 = 0.125 of CH3 (at 0.9 ppm) to 
CH2 (at 1.3 ppm). The middle panel shows how introduction of a single double bond increases this ratio to 
3/16 = 0.188, due not only to the desaturation of two CH2, but also to the alteration in the chemical environment 
of the neighbouring CH2. For FA chains of equal number of double bonds, the CH3:CH2 ratio will also be scaled 
by chain length, although this will have a proportionally smaller effect (lower panel). SFA, saturated FA; MUFA, 
monounsaturated FA; PUFA, polyunsaturated FA. (B) Results in phantoms. The graph on the right of the panel 
shows data from agar phantoms simulating IMCL (oil droplets) and extramyocellular lipid (EMCL; oil-soaked 
tissue roll) made using olive, rapeseed, sunflower and cod liver oils. Three 1H spectra were acquired from each 
phantom and the IMCL CH3:CH2 ratio correctly distinguished the order of four oil phantoms. On the left of the 
panel is a representative 1H spectrum (solid black) acquired from a voxel containing both simulated IMCL and 
EMCL compartments, also showing the overall fit (dashed grey) and individual fit components (solid grey).  
(C) Results in vivo. The figure shows a representative 1H spectrum from soleus in vivo, showing the fit to EMCL 
and IMCL CH2 and CH3 resonances.
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The two muscles also responded differently to fasting. The increment in SOL correlated with concentrations 
of combined saturated 14:0 and 16:0 FA, and of 16:0 alone (Fig. 3C), and appeared unrelated (p > 0.4) to mono-
unsaturated (MUFA) or polyunsaturated fatty acids (PUFA). This agrees with rat biopsy observations of soleus 
TG after 48 h fast where only 16:0 and 18:0 FA increased14. By contrast the increment in TA CH2/Cr was strongly 
related to circulating MUFA (p < 0.003), with a tendency for PUFA (p = 0.06), and not related to any individual 
or combined saturated FA (p > 0.3). Figure 3B shows the correlation with oleic acid concentration, the main cir-
culating MUFA24. This suggests a differing net uptake of FA into IMCL during fasting, with the influx of FA with 
a higher CH3:CH2 ratio into the TA muscle IMCL pool, this is a profile which matches the baseline composition. 
It is unknown whether this differing uptake is a result of selective FA transporters or of a differing FA profile 
remaining after short-chain and unsaturated FA are preferentially oxidised13,25.
Summary and implications. We have shown by practical validation in IMCL/EMCL simulated phantoms, 
that the IMCL CH3:CH2 ratio in good-quality spectra showing clear distinction between EMCL and IMCL CH2 
resonances, acquired at 3 T using the PRESS sequence with a short echo time of 35 ms is a comparative marker 
of TG composition. These acquisition parameters are commonly used, and therefore this method has potential 
for widespread use. Although this marker does not distinguish saturated from mono- or poly-unsaturated FA 
components of TG, as recently achieved using a specialised sequence26, it is particularly sensitive to differ-
ences in the degree of unsaturation and chain length. We stimulated lipolysis using an extended fast in healthy 
adult males and showed evidence of IMCL turnover, such that IMCL is synthesized from circulating FFA and 
hydrolysed causing a selective efflux of unsaturated and/or shorter chain FA. This combination of in vivo MRS 
measurements of IMCL CH2, CH3 and CH3:CH2 with measurements of plasma FFA has the potential to inform 
on both the composition and net dynamics of this metabolically-active pool. Although isotopic tracer stud-
ies such as pulse-chase approaches performed in vivo27 may provide more definitive mechanistic information 
underlying the turnover of a specific FA species in intramuscular triglyceride, 1H MRS offers the ability to 
detect the intramyocellular triglyceride pool non-invasively, allowing repeated measures from the same sample 
conveniently in a timeframe of a few minutes, permitting investigation of net changes of all FA species both 
within short-term and over longitudinal intervention studies. The 1H MRS method outlined here, together with 
isotopic tracer studies, have the potential to better define the involvement of IMCL in insulin-resistant states 
and their treatments.
Methods
Phantom validation of IMCL compositional marker. Four agar phantoms simulating IMCL (oil drop-
lets) and EMCL (oil-soaked tissue roll)19 were made using lipids of differing fatty acid (FA) compositions viz. 
olive, rapeseed, sunflower and cod liver oils. These are composed of triglycerides which, on average, increase 
in degree of unsaturation from predominantly 18:1 (olive) to predominantly 18:2 (sunflower), to a mixture of 
highly unsaturated and shorter-chain FA (cod liver oil). The same oil was used in both droplet and tissue roll 
8 h 28 h P value
Intra- and extramyocellular lipid
  Soleus
 SOL IMCL CH2/Cr 8.5 ± 1.0 10.7 ± 0.9 0.007
 SOL IMCL CH3/Cr 1.02 ± 0.12 1.14 ± 0.11 0.243
 SOL IMCL CH3:CH2 0.118 ± 0.004 0.106 ± 0.004 0.015
 SOL EMCL CH2/Cr 16.3 ± 2.3 16.6 ± 1.8 0.735
  Tibialis anterior
 TA IMCL CH2/Cr 4.2 ± 0.4 5.5 ± 0.4  < 0.001
 TA IMCL CH3/Cr 0.77 ± 0.09 0.86 ± 0.07 0.033
 TA IMCL CH3:CH2 0.182 ± 0.011 0.157 ± 0.008 0.011
 TA EMCL CH2/Cr 10.2 ± 1.2 12.2 ± 1.6 0.157
Adipose tissue
SCATabd, cm3 781 ± 86 758 ± 81 0.012
VAT, cm3 336 ± 67 335 ± 69 0.650
SCATleg, cm2 13.1 ± 1.0 12.7 ± 1.0 0.001
IMF, cm2 2.4 ± 0.3 2.5 ± 0.2 0.274
Hepatic lipid
IHL CH2/water, % 0.91 ± 0.2 0.93 ± 0.2 0.082
Table 1. Magnetic resonance measures at 8 h and 28 h of fasting. Data are mean ± SEM. Bold P values are 
statistically significant (p < 0.05), determined by a 2-tailed paired-samples t-test. IMCL, intramyocellular 
lipid; EMCL, extramyocellular lipid; SOL, soleus; TA, tibialis anterior; CH2/Cr, CH2 lipid expressed relative 
to the chosen internal standard creatine plus phosphocreatine (Cr); CH3/Cr, CH3 lipid expressed relative 
to Cr; CH3:CH2, CH3 lipid relative to CH2 lipid, used here as a marker of unsaturation; SCATabd, abdominal 
subcutaneous adipose tissue; VAT, visceral adipose tissue; SCATleg, leg subcutaneous adipose tissue; IMF, 
intermuscular fat; IHL, intrahepatic lipid. n = 19 and 22 in SOL and TA respectively.
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compartments, with the exception of the cod liver oil where the tissue roll was olive oil. Three 1H MR spectra were 
acquired from each phantom using the Point Resolved Spectroscopy sequence with the short echo time (TE) of 
35 ms.
Participants and protocol. 24 healthy non-obese Caucasian male volunteers were recruited, aged 18 to 50 
years without diabetes and taking no medication28. They were asked to refrain from alcohol and vigorous physical 
activity and to follow their normal diet for 3 days prior to the study. Their meal on the evening prior to the study 
Figure 2. In vivo IMCL compositional marker at baseline (8 h fasting) and alterations after extended fasting 
(28 h) in both the tibialis anterior (TA) and soleus (SOL) muscles. The IMCL CH3:CH2 ratio is a marker of 
the degree of unsaturation combined with reduced chain length. (A) Fasting compositional changes in IMCL 
relate to the baseline composition. Correlations in the TA (black diamonds; Pearson’s r = −0.73, p < 0.001, 
n = 22) and SOL (grey circles; r = −0.63, p = 0.004, n = 19) muscles, and TA and SOL together (r = −0.67, 
p < 0.001, n = 41). The overall ΔIMCL CH3:CH2 significantly decreased in both muscles during the fast (both 
p < 0.015; paired samples t-test, Table 1). Due to the short TE, T2 correction would be minimal (estimated to 
alter CH3:CH2 values by ~10%), and is not shown. (B) Fasting compositional changes in IMCL relate to fasting 
alterations in IMCL CH3/Cr. Correlations in the TA (black diamonds; Pearson’s r = 0.58, p = 0.005, n = 22) and 
SOL (grey circles; r = 0.67, p = 0.002, n = 19) muscles, and TA and SOL together (r = 0.52, p < 0.001, n = 41). 
Decreases in the compositional marker (ΔCH3:CH2) are associated with decreases in ΔCH3/Cr i.e. where there 
is net efflux (as ΔCH3/Cr reflects net flux). (C) IMCL CH2/Cr relative to CH3/Cr at baseline reveals differences 
in IMCL CH3:CH2 ratio between TA (black diamonds) and SOL (grey circles) muscles (p < 0.001; paired 
samples t-test; n = 19).
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(at 19:30) and following breakfast on day 1 (at 07:30) were standardized based on one-third of the recommended 
daily intake of energy and contained approximately 50% carbohydrate, 30% fat, and 20% protein. The study pro-
tocol involved fasting from 08:00 on day 1 to 14:00 on day 2. Magnetic resonance evaluations were undertaken at 
8 and 28 h of fasting (16:00 on day 1 and noon on day 2) on a whole-body Siemens 3 T Verio scanner (Erlangen, 
Germany), with the voxels/slices being carefully relocalised on the second visit. Overnight blood samples for FFA 
assessment using high resolution mass spectrometry were taken at 20:00 (Day 1), 00:00 and 08:00 (Day 2).
Intramyocellular lipid (IMCL). Participants were placed supine and the peripheral-angio coil used for sig-
nal reception. A water-suppressed proton spectrum was acquired from a voxel of cube length 1.3 cm positioned to 
avoid visible fat on T1-weighted images within TA and SOL, using acquisition parameters as in the phantom val-
idation (TE = 35 ms, 5 s repetition time, and 64 averages). Phantom and in vivo data were analysed in jMRUI29,30 
Figure 3. Circulating free fatty acids (FFA) (µmol/l, AUC) analysis after 12, 16 and 24 h fasting, and their 
relationship with the difference (Δ) in muscle IMCL CH2 between 8 and 28 h fasting. (A) FFA profile 
(mean ± SEM): total saturated FFA (white bars) constitute 41.9 ± 1.0%, total monounsaturated (grey bars) 
43.3 ± 0.8%, total polyunsaturated (black bars) 14.8 ± 0.4%, and total omega-3 (18:3, 22:5, 22:6) 1.62 ± 0.06% 
of total FFA. (B) and (C) show correlations: TA ΔIMCL CH2 (n = 22) was significantly correlated with 
concentrations of total monounsaturated (Pearson’s r = 0.60, p = 0.003) FFA and specifically 18:1 (r = 0.64, 
p = 0.002) (shown in B), as well as total omega-3 FFA (r = 0.43, p = 0.046) with a tendency for total 
polyunsaturated FFA (r = 0.41, p = 0.06). In contrast SOL ΔIMCL CH2 (n = 19) correlated with combined 
saturated 14:0 + 16:0 (r = 0.52, p = 0.02) and 16:0 FFA alone (r = 0.49, p = 0.03) (shown in C).
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and fitted with the AMARES31 algorithm using identical prior knowledge parameters: a single EMCL resonance, 
Gaussian lineshapes, soft constraints on EMCL/IMCL CH2 frequencies and linewidths, CH3 resonant frequencies 
and linewidths determined from known and inferred prior knowledge relative to the CH2 resonance5, and with 
all amplitudes estimated. IMCL CH2 and CH3 are expressed relative to the creatine and phosphocreatine CH3 
resonance at 3.0 ppm.
Free Fatty Acids (FFA). Plasma samples were extracted with MTBE using an automated liquid handler. This 
organic phase was diluted with a mixture of isopropanol/methanol with 7.5 mM NH4Ac solution. Lipid profiling 
was performed on the extract using chip-based nanoelectrospray with an Advion TriVersa Nanomate (Advion, 
Ithaca, USA) interfaced to the Thermo Exactive Orbitrap (Thermo Scientific, Hemel Hampstead, UK), using a 
mass acquisition window from 200 to 2000 m/z and acquisition in positive and negative mode, as described else-
where32. Negative mode data were used to measure relative concentrations of free fatty acids (FFA), and absolute 
FFA concentrations were calculated by comparison to the added internal standard undecanoic acid. Circulating 
FFA composition was reported from plasma samples at 12, 16 and 24 h fast, combined as the AUC.
Adipose tissue. Abdominal subcutaneous (SCATabd) and visceral (VAT) adipose tissue volumes were 
measured using magnetic resonance imaging over 6 cm superior-inferior distance from 5 water-suppressed 
T1-weighted transaxial slices above the L5 vertebral level. Due to the higher reproducibility of leg subcutaneous 
adipose tissue (SCATleg) and intermuscular fat (IMF) (2 or 3% CoVs), these measures were assessed from a single 
T1-weighted transaxial slice central to the 1H MRS voxels, and hence these measures have units of area (cm2). 
Regional MRI analysis was performed in Analyze (AnalyzeDirect, Overland Park, KS).
Intrahepatic lipid (IHL). IHL was measured by 1H MRS as previously described33, and expressed as the 
methylene peak at 1.3 ppm relative to the water peak.
Statistics. All statistical tests were performed in IBM SPSS Statistics 23 (IBM, Armonk, NY: IBM Corp.), with 
significance set at P < 0.05. Normality was assessed by the Shapiro-Wilk test and non-normally distributed data 
were log-transformed prior to statistical testing. A 2-tailed paired-samples t-test was used to compare differences 
between 8 h and 28 h of fasting and Pearson’s correlation coefficient for analyzing relations. Data are mean ± SEM.
Study approval. The study was approved by the Cambridge Local Research Ethics Committee and con-
ducted in accordance with the Declaration of Helsinki. All participants provided written informed consent.
Data Availability. The datasets generated during the current study are available from the corresponding 
author on reasonable request.
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